Risk factors and mortality rates of carbapenem-resistant Gram-negative bacterial infections in intensive care units

Introduction (Article introduction authored by ICU Editorial Team) In recent years, the prevalence of hospital-acquired infections caused by carbapenem-resistant Gram-negative bacteria (CRGNB) has increased globally, posing significant threats to patient…

Continue ReadingRisk factors and mortality rates of carbapenem-resistant Gram-negative bacterial infections in intensive care units

Corticosteroids in Sepsis and Septic Shock: A Systematic Review, Pairwise, and Dose-Response Meta-Analysis

Introduction (Article introduction authored by ICU Editorial Team) The utilization of corticosteroids in the management of sepsis and septic shock has remained contentious despite extensive examination through randomized controlled trials…

Continue ReadingCorticosteroids in Sepsis and Septic Shock: A Systematic Review, Pairwise, and Dose-Response Meta-Analysis

Role of nebulized colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective cohort study

Introduction Nosocomial pneumonia caused by carbapenem-resistant Gram-negative bacteria (CR-GNB) is a growing concern worldwide due to limited treatment options and poor prognosis. VAP-prevention strategies have recently been grouped together into…

Continue ReadingRole of nebulized colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective cohort study

Aerosolized Antibiotics to Manage Ventilator-Associated Infections: A Comprehensive Review

Introduction Critically ill patients on ventilators are prone to lower respiratory tract infections, ranging from tracheal tube colonization to ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumonia (VAP). VAP is associated with…

Continue ReadingAerosolized Antibiotics to Manage Ventilator-Associated Infections: A Comprehensive Review

A multisite evaluation of antifungal use in critical care: implications for antifungal stewardship

Introduction ICUs are settings of high antifungal consumption. Excessive antifungal use may cause individual and collective harm due to treatment-related adverse effects, drug–drug interactions and the selection of drug-resistant fungi,…

Continue ReadingA multisite evaluation of antifungal use in critical care: implications for antifungal stewardship

Utility of plasma cell-free DNA next-generation sequencing for diagnosis of infectious diseases in patients with hematological disorders

Introduction Infection is one of the most common complications for patients with neutropenia and can lead to high mortality if inappropriate empirical antibiotic treatment is administered. Accurate and timely pathogen…

Continue ReadingUtility of plasma cell-free DNA next-generation sequencing for diagnosis of infectious diseases in patients with hematological disorders

Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development

Introduction The overuse of carbapenem antibiotics has resulted in an increase in carbapenem-resistant gram-negative bacterial infections, posing a significant public health threat. These infections are prevalent in intensive care units…

Continue ReadingCarbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development

Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?

Introduction Invasive fungal infections are an important cause of morbidity and mortality, especially in critically ill patients Increasing resistance rates and inadequate antifungal exposure have been documented in these patients,…

Continue ReadingTherapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?